Search results

51. Molecular classification of stage III cutaneous melanoma - genetic alterations in selected pathways and aCGH-based chrom…

Principal investigator: prof. Piotr Łukasz Rutkowski

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Call: OPUS 2, Panel: NZ5

52. Study on the use of primary cultures and established cell lines of canine lymphoma in the diagnosis and treatment of lym…

Principal investigator: Aleksandra Pawlak

Uniwersytet Przyrodniczy we Wrocławiu

Call: PRELUDIUM 1, Panel: NZ5

53. Application of probiotic extracellular vesicles in the treatment of chronic wounds with concomitant fungal infection.

Principal investigator: Katarzyna Daria Kowalik

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ6

54. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud…

Principal investigator: prof. Gabriel Piotr Nowak

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

55. Genetic background of chromothripsis, its role in clonal evolution and response to therapy in childhood acute lymphoblas…

Principal investigator: dr hab. Agata Karolina Pastorczak

Uniwersytet Medyczny w Łodzi

Call: OPUS 27, Panel: NZ5

56. Identification of circulating biomarkers for monitoring anti-CD19 CAR-T cell treatment response in patients with aggress…

Principal investigator: Monika Szelest

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 23, Panel: NZ5

57. Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from mole…

Principal investigator: dr Artur Świerczek

Uniwersytet Jagielloński, Collegium Medicum

Call: SONATA 19, Panel: NZ7

58. A new generation of scaffolds based on curdlan and whey protein isolate obtained by electrospinning for the treatment of…

Principal investigator: dr Katarzyna Klimek

Uniwersytet Medyczny w Lublinie

Call: SONATA 19, Panel: NZ7

59. Molecular profiling of soft tissue sarcomas in tumor and peripheral blood in terms of response to treatment and early de…

Principal investigator: prof. Piotr Łukasz Rutkowski

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Call: OPUS 25, Panel: NZ5

60. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

Principal investigator: dr Anna Katarzyna Florczak-Substyk

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA 17, Panel: NZ7

61. Bioabsorbable hydroxyapatite/polymer nanocomposite granules with enhanced osteoconductivity and anti-inflammatory proper…

Principal investigator: dr Vladyslav Vivcharenko

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 20, Panel: NZ7

62. An innovative method of treating acute liver failure using amniotic stem cells isolated from the human placenta.

Principal investigator: dr Patrycja Lukrecja Wieczorek

Śląski Uniwersytet Medyczny w Katowicach, Centrum Medycyny Doświadczalnej

Call: PRELUDIUM 20, Panel: NZ7

63. Antagonizing detrimental cytokine signaling and angiogenesis to expand access and duration of PD treatment

Principal investigator: prof. Janusz Cezary Witowski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 20 (LAP), Panel: NZ4

64. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

Principal investigator: prof. Małgorzata Kucińska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA 16, Panel: NZ7

65. Usefulness of liquid biopsy" in diagnostics, stratification, and monitoring of therapy in non-small cell lung cancer pat…

Principal investigator: dr hab. Joanna Natalia Budna-Tukan

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Call: PRELUDIUM BIS 2, Panel: NZ5

66. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan…

Principal investigator: prof. Andrzej Mikołaj Pilc

Instytut Farmakologii PAN

Call: OPUS 19, Panel: NZ7

67. Glycoconjugated zinc phthalocyanine as a novel photodynamic therapy tool for the treatment of psoriasis

Principal investigator: prof. Piotr Paweł Ziółkowski

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: PRELUDIUM BIS 1, Panel: NZ4

68. Curcuminoid-polyphenol conjugates as potential therapeutics for urinary system cancer treatment

Principal investigator: prof. Tomasz Adam Gośliński

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: OPUS 18, Panel: NZ7

69. Nasal administration of probiotics - development of an allergic rhinitis in vitro model and the assessment of probiotic …

Principal investigator: Marcelina Joanna Pyclik

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 17, Panel: NZ7

70. Hypoxia in combinatory treatment of murine pancreatic tumor

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 15, Panel: NZ5

71. Assessment of the usefulness of shear wave sonoelastography in the diagnosis and monitoring of the management of increas…

Principal investigator: Anna Olchowy

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarsko-Stomatologiczny

Call: PRELUDIUM 14, Panel: NZ5

72. Mutational load in children with prelingual deafness - searching for a novel predictive factor to assess the outcome of …

Principal investigator: dr Dominika Daria Oziębło

Instytut Fizjologii i Patologii Słuchu

Call: PRELUDIUM 14, Panel: NZ5

73. The assesment of endothelium considering role of endothelial progenitor cells and leukotrienes synthesis in patients wit…

Principal investigator: Agnieszka Wachsmann

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: PRELUDIUM 14, Panel: NZ5

74. Determination of arginase-1 as a potential drug target in the treatment of multiple myeloma and in reducing proteasome i…

Principal investigator: prof. Jakub Adam Gołąb

Warszawski Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 13, Panel: NZ6

75. Oral supplementation of piglets with iron nanoparticles and liposomial iron as an innovative therapy in treating neonata…

Principal investigator: dr hab. Rafał Radosław Starzyński

Instytut Genetyki i Hodowli Zwierząt PAN

Call: OPUS 13, Panel: NZ9

76. Quantitative ultrahigh field magnetic resonance imaging techniques as potential biomarkers of response in patients treat…

Principal investigator: dr hab. Radosław Rola

Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

Call: OPUS 12, Panel: NZ5

77. Use of novel small molecule inhibitors of PERK kinase dependent UPR pathway for the primary open-angle glaucoma treatmen…

Principal investigator: prof. Ireneusz Jacek Majsterek

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: OPUS 11, Panel: NZ5

78. Products of DNA demethylation and deamination pathways as new biomarkers of development and predictors of the outcome in…

Principal investigator: dr hab. Daniel Stefan Gackowski

Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

Call: OPUS 10, Panel: NZ5

79. Clinical, biochemical and genetic factros for response to antibody anti-IgE treatment in asthma phenotypes

Principal investigator: prof. Lucyna Maria Mastalerz

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 10, Panel: NZ5

80. Non-quinazoline antagonists of apha1 and 5-HT2A receptors with pleiotropic effects as a new perspective for hypertension…

Principal investigator: dr Monika Kubacka

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Call: SONATA 8, Panel: NZ7

81. Molecular analysis of clear cell renal cell carcinoma progression in the context of the search for predictive factors pr…

Principal investigator: dr Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: SONATA 5, Panel: NZ5

82. Genetic background of aminoglycoside-induced hearing loss - mitochondrial and nuclear genes involvement

Principal investigator: dr Małgorzata Aleksandra Rydzanicz

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Call: SONATA 5, Panel: NZ5

83. Influence of individual genetic host factors, associated with DNA damage, antioxidant defence, metastasis and angiogenes…

Principal investigator: dr hab. Dorota Butkiewicz

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Centrum Onkologii Instytut im. M Skłodowskiej–Curie Oddział w Gliwicach

Call: OPUS 3, Panel: NZ5

84. The use of second generation ultrasound contrast agents as an additional element of the diagnosis, monitoring treatment …

Principal investigator: dr Maciej Paweł Piskunowicz

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: OPUS 3, Panel: NZ5

85. Could the new diagnostic methods be useful in opimalizing the choice of treatment of asymptomatic patients with signific…

Principal investigator: dr hab. Ewa Hanna Orłowska-Baranowska

Instytut Kardiologii im. Prymasa Tysiąclecia Stefana Kardynała Wyszyńskiego

Call: OPUS 2, Panel: NZ7

86. The clinical application of gene expression in the treatment of insect venom alergy, diagnosis and the assessment of the…

Principal investigator: dr hab. Marek Niedoszytko

Gdański Uniwersytet Medyczny

Call: HARMONIA 1, Panel: NZ5

87. Project evaluation of diagnostic, treatment and costs in patients with heart failure among randomly selected outpatient …

Principal investigator: prof. Tomasz Kazimierz Grodzicki

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 1, Panel: NZ7

88. Targeting MMP-9 in Cancer Treatment: Computational Design and Experimental Validation of Potent, Safe Antitumor Agents

Principal investigator: dr Anna Żądło-Dobrowolska

Instytut Chemii Organicznej Polska Akademia Nauk

Call: SONATA BIS 15, Panel: ST5

89. Raman spectroscopy guided assessment of vascular niche microenvironmentinfluence on leukemic myeloid progenitors and leu…

Principal investigator: dr Adriana Justyna Adamczyk

Uniwersytet Jagielloński

Call: OPUS 29, Panel: ST4

90. 3D Bioprinted Fiber-Enriched Gradient Scaffolds for Guiding MSC Differentiation in Big Trauma

Principal investigator: Daniel Rybak

Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

Call: PRELUDIUM 24, Panel: ST11

91. Flavonoid phytoprogestins as novel non-steroidal progesterone receptor modulators in a nutraceutical approach to endomet…

Principal investigator: Agata Gołąbek-Grenda

Uniwersytet Przyrodniczy w Poznaniu

Call: PRELUDIUM 24, Panel: NZ9

92. Electrospun plant protein-based dressings functionalized with hirudin for chronic wound healing

Principal investigator: Katarzyna Marszalik

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

Call: PRELUDIUM 24, Panel: ST11

93. Smart Multiscale Encapsulation System: Hydrogel Macrocapsules with LbL Nanoparticles for Colorectal Cancer Treatment

Principal investigator: Joanna Irena Szechyńska

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: PRELUDIUM 24, Panel: ST11

94. New aryl difluoromethylenephosphonic acid and thiazole conjugates as effective PTP1B inhibitors used in the treatment of…

Principal investigator: Dominika Agnieszka Kołodziej-Sobczak

Uniwersytet Mikołaja Kopernika

Call: PRELUDIUM 24, Panel: ST5

95. Synthesis and Functionalization of Hyperbranched Polypeptides for Osteoarthritis Treatment

Principal investigator: dr hab. Monika Gosecka

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: SHENG 4, Panel: ST11

96. Preparation of pollen-like advanced drug delivery carriers for the treatment of chronic obstructive pulmonary disease

Principal investigator: prof. Elżbieta Pamuła

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

Call: SHENG 4, Panel: ST5

97. Developing histone deacetylase-inhibiting hybrid analogs of pleurocidin and their potential in the treatment of HPV-indu…

Principal investigator: dr hab. Ewelina Piktel

Uniwersytet Medyczny w Białymstoku

Call: SONATA 20, Panel: NZ7

98. Modulating Neuroplasticity with Psilocybin: Assesment Therapeutic Potential in Treating Fentanyl use disorder

Principal investigator: dr hab. Ewa Taracha

Instytut Psychiatrii i Neurologii

Call: OPUS 28, Panel: NZ7

99. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c…

Principal investigator: dr hab. Monika Emilia Marcinkowska

Uniwersytet Jagielloński

Call: OPUS 28, Panel: NZ7

100. Biotechnological method for production of 8-prenylnaringenin for application in treatment of inflammatory skin diseases

Principal investigator: dr Jan Paweł Krzysztoforski

Politechnika Warszawska

Call: SONATA 20, Panel: ST8

Projects search